NZ's Fisher & Paykel Healthcare rises on outlook upgrade
** Fisher & Paykel Healthcare FPH.NZ rises as much as 6.6% to NZ$39.79; marks biggest intraday pct gain since November 26, 2025 ** Co upgrades FY26 NPAT guidance to NZ$450 mln ($269.9 mln)-NZ$470 mln range from NZ$410 mln-NZ$460 mln range ** CEO says, "We have continued to see good growth across the full range of our Hospital products so far during our second half" ** YTD, FPH up 4.8% ($1 = NZ$1.6672) (Reporting by Nichiket Sunil in Bengaluru) ((Nichiket.Sunil@thomsonreuters.com))
Recent news on Fisher & Paykel Healthcare
See all newsNZ's Fisher & Paykel Healthcare slips, Morningstar says co overvalued
Morningstar says NZ's Fisher & Paykel Healthcare overvalued
Refile: BRIEF-Fisher & Paykel Healthcare Posts FY Net Income NZ$468.5 Mln
Brief: Fisher Paykel Healthcare Sees FY Operating Revenue To Be In Range Of NZ$2.45 Billion To NZ$2.57 Billion
New Zealand's Fisher & Paykel Healthcare rises on upbeat FY27 earnings forecast